MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $557,384 | -7.6% | 23,638 | +3.1% | 0.01% | -14.3% |
Q2 2023 | $603,536 | +186176.5% | 22,922 | +30.1% | 0.01% | +40.0% |
Q1 2023 | $324 | -9.7% | 17,615 | -24.1% | 0.01% | -28.6% |
Q4 2022 | $359 | -99.9% | 23,215 | +0.7% | 0.01% | -30.0% |
Q3 2022 | $462,000 | -6.3% | 23,045 | +5.9% | 0.01% | -23.1% |
Q2 2022 | $493,000 | +30.8% | 21,765 | +52.5% | 0.01% | +44.4% |
Q1 2022 | $377,000 | -36.1% | 14,269 | -23.1% | 0.01% | -10.0% |
Q4 2021 | $590,000 | – | 18,549 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |